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This study  assessed  the  protective  effect  of the  carotenoid  bixin  and annatto  seeds  against  possible
nephrotoxicity  induced  with  a single  peritoneal  administration  of pharmacological  cisplatin  in male
Wistar  rats.  After 48  h, the  blood  cell  differential  count  showed  a  signiﬁcant  reduction  in neutrophil
counts  in rats  that  received  a  diet  rich  in bixin  when  compared  to the  group  that  received  only  cisplatin.eywords:
isplatin
ixin
nnatto
ell differentiation
ephrotoxicity
The  use  of  cisplatin  led  to  an  increase  in  kidney  weight.  The  carotenoid  bixin  attenuated  renal  injury,  char-
acterized  by  increased  polymorphonuclear  inﬁltration.  No  protective  effect  was  observed  with  respect  to
Annatto.  These  results  demonstrate  the  role of  toxic  cisplatin  and  suggest  that  bixin  affords  a protective
effect  against  cisplatin-induced  nephrotoxicity  in  adult  Wistar  rats.
© 2016  Sociedade  Brasileira  de  Farmacognosia.  Published  by Elsevier  Editora  Ltda.  This  is  an  open
access  article  under  the  CC BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).ntioxidant
ntroduction
Cisplatin [cis-diamminedichloroplatinum(II) – CDDP] is a
hemotherapeutic agent used alone or in combination with other
ntineoplastic agents in the treatment of lung, brain, throat, esoph-
gus, stomach, colon, bladder, testicular, ovarian and uterine and
ther cancers. However, cisplatin nephrotoxicity is the principle
ose-limiting factor for the use of cisplatin (Santos et al., 2012). It
as been suggested that the generation of reactive oxygen species
nd lipid peroxidation is responsible for the cisplatin-induced renal
ubular impairment (Chirino and Pedraza-Chaverri, 2009).
The physiological functions of patients undergoing chemother-
py should be monitored using periodic laboratory tests to analyze
arameters of global renal function, such as creatinine and urea,
nd obtain the blood cell count to determine general immune status
Sodré et al., 2007).
Carotenoids are compounds that have antioxidant properties
apable of sequestering free radicals. They are found in various
oods and may  have a protective effect against oxidative damage
∗ Corresponding author.
E-mail: luceia.souza@ufrgs.br (L.F. Souza).
http://dx.doi.org/10.1016/j.bjp.2016.03.005
102-695X/© 2016 Sociedade Brasileira de Farmacognosia. Published by Elsevier Edit
reativecommons.org/licenses/by-nc-nd/4.0/).caused, for example, by chemotherapy (Antunes and Bianchi, 2004;
Rios et al., 2009; Bautista et al., 2004).
Annatto is a natural color extracted from the outer coating of
the seeds of the Annatto tree (Bixa orellana L., Bixaceae), which is
native to the Amazon region in South America (Mercadante, 2001;
Gomes, 2007). Its color varies from yellow to red, and the most
abundant carotenoid is trans-bixin (1), which accounts for around
80% of the total pigment content of the seeds (Mercadante, 2001;
Giuliano et al., 2003; Bautista et al., 2004). In addition to its coloring
action, annatto also has functional properties that form the basis
of a variety of roles and actions in living organisms due to the
presence of antioxidant compounds (Krinsky, 1994). Studies have
shown that bixin has beneﬁcial effects, including the reduction
of oxidative stress and its ability to act as a chemo-preventative
agent and to reduce the nephrotoxic effects of antitumor agents
(Bertram and Bortkewicz, 1995; Agner et al., 2005; Rios et al., 2009).
H3CO CO2H
O
1
In an attempt to minimize the side effects caused by cisplatin,
this study evaluates the antioxidant activity of the carotenoid bixin
ora Ltda. This is an open access article under the CC BY-NC-ND license (http://
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nd annatto seeds on cisplatin-induced nephrotoxicity in adult
ale Wistar rats by examining biochemical and histological aspects
o assess renal function and morphology and performing complete
lood counts.
aterials and methods
lant material
This study examined annatto (Bixa orellana L., Bixaceae) from the
ldorado access, ICN (189644) 10.VII.2009, collected and identiﬁed
y J.M. Wiest.
ssays
nimals
The biological assay was performed in the Vivarium of the Food
cience Department of the Institute of Food Science and Technology
f the Federal University of Rio Grande de Sul in Brazil. The ani-
als were housed in ventilated rooms at a temperature of 24 ± 2 ◦C
ith a 12–12 h light–dark cycle and 60 ± 5% humidity and given ad
ibitum access to food and water.
The animals were divided at random into four groups: CG (con-
rol group), CPG (cisplatin group), CPBG (cisplatin/bixin group),
nd CPAG (cisplatin/annatto group). The biological trial lasted
8 days. The CG group received commercial rodent feed, the
PG group received commercial feed plus cisplatin (5 mg  kg−1
ody weight), the CPBG group received commercial feed with
ixin (0.065 mg  kg−1 body weight) and cisplatin (5 mg  kg−1 body
eight), and the CPAG group received commercial feed with cis-
latin (5 mg  kg−1 body weight) and annatto (0.500 mg  kg−1 body
eight). The doses of bixin and annatto used in pretreatment were
ased on data found in the literature on nephroprotective effects
FAO/WHO, 2007; Antunes and Bianchi, 2004). A single dose of
isplatin (5 mg  kg−1) was administered 48 h before the end of the
xperiment to induce oxidative stress.
btaining annatto and bixin crystals
Bixin crystals were obtained using a methodology developed by
ios and Mercadante (2004). The seeds were ﬁrst washed in hexane
nd methanol to remove hydrophilic and hydrophobic impurities
nd the bixin was then extracted using ethyl acetate. The extract
btained through this process was dried in a rotary evaporator
T < 30 ◦C) and rediluted in dichloromethane. For the crystalliza-
ion process, the extract was heated on a hot plate (T < 50 ◦C). After
eing chilled, absolute ethanol was added and the extract was  then
ooled in an ice bath and placed in a freezer at 14 ± 2 ◦C for 24 h.
he bixin crystals were ﬁltered and washed with chilled absolute
thanol, dried in a vacuum oven for 24 h, and then stored at −18 ◦C
ntil use.
uriﬁcation of bixin
The purity of bixin was determined using a method described
y Tocchini and Mercadante (2001), in which the bixin is extracted
rom annatto seeds previously washed with petroleum ether and
 mixture of methanol and dichloromethane (1:1). After concen-
ration, the extract was successively puriﬁed by silica gel thin layer
hromatography using both ethyl acetate and petroleum ether (3:2)
s mobile phases. In the ﬁrst chromatography, silica gel layers
Merck) were prepared in the laboratory and the two separated
ands and everything remaining at the origin were scraped off and
luted with the methanol/dichloromethane mixture (1:1). After
oncentration, the band was applied again to ready silica plates and
plit into two bands. The major one at Rf 0.61 was  scraped off andrmacognosia 26 (2016) 446–450 447
eluted with the methanol/dichloromethane mixture. The pattern
obtained shows 99% purity, checked by High Performance Liquid
Chromatography (HPLC) (Agilent 1100 series).
Cisplatin
Cisplatin [cis-diamminedichloroplatinum (II), CDDP; CAS No.
15663-27-1] was  kindly donated in its commercial form by Quiral
Química do Brasil S.A. (Platinil®).
Blood collection and doses of urea and creatinine
The animals were sedated for blood collection using benzoadi-
azepine (0.25 mg  100 g−1 body weight) and sodium pentobarbital
(4.6 mg  100 g−1 body weight). A median incision was  made in
the ventral part of the abdomen and blood was  collected from
the ascending aorta. The blood was centrifuged for 10 min at
5081.31 × g force to separate serum for urea and creatinine analy-
ses.
Urea and creatinine levels were determined using commercial
kits (Bio Liquid). Urea was quantiﬁed using a spectrophotome-
ter (Micronal – B342II digital model) adopting the UV kinetic
method, while creatinine was  quantiﬁed using the colorimetric
kinetic method. The results were expressed in mg/dl.
Blood cell differential count
The blood collected from the aorta was placed into ﬂasks con-
taining EDTA solution. The animals were subsequently sacriﬁced.
The blood smears were stained (Instant Prov – New Prov) and
manually analyzed to determine the blood cell differential count
using an optical microscope. The blood cell differential count was
expressed as a percentage (%).
Determination of kidney weight and preparation for histological
analysis
The kidneys were washed free of blood (by perfusion) with
a saline solution. A ﬁxing solution was  then added and the kid-
neys were weighed using a Micronal B 600 balance and ﬁxed using
Bouin’s solution for 24 h at room temperature.
The material was prepared for histological analysis using routine
techniques (Prophet et al., 1994). After ﬁxing for 24 h, the sample
tissues were cryoprotected using sucrose solutions at increasing
concentrations (from 15% to 30%) and then frozen in nitrogen. Next,
using a cryostat (Leitz, Digital 1702, Germany) at −20 ◦C, each piece
was cut at 15 m thickness intervals and the slice were placed on
glass slides and stained using hematoxylin and eosin (HE) to assess
tissue morphology. Histological parameters were obtained using
an Olympus® Bx50 optical microscope (Olympus, Tokyo, Japan).
Ethical aspects
This study was approved by the Animal Research Ethics Com-
mittee of the Federal University of Rio Grande do Sul (reference
number 17809), being considered ethically and methodologically
adequate according to Resolution 196/1996 and complementary
items of the Brazilian National Health Council.
Statistical analysisData was submitted to an analysis of variance (ANOVA) to detect
signiﬁcant differences between study groups. Tukey’s test was
applied to identify any difference between means using a signif-
icance level of p ≤ 0.05.
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Table  1
Means and standard deviations of blood cell differential counts in Wistar rats subjected to different treatments.
CG (n = 6) CPG (n = 6) CPBG (n = 6) CPAG (n = 6)
Neutrophils (%) 16.5 ± 4.9 24.6 ± 9.2a 13.5 ± 3.5a 18.33 ± 3.7
Lymphocytes (%) 73.3 ± 3.9 67.4 ± 9.0 75.5 ± 5.7 72.50 ± 3.2
Monocytes (%) 8.0 ± 2.7 7.8 ± 1.9 10 ± 3.6 9.0 ± 4.1
Basophils (%) 0.2 ± 0.4 0.2 ± 0.4 0.3 ± 0.8 0.16 ± 0.4
Eosinophils (%) 1.3 ± 1.0 0.4 ± 0.9 0.3 ± 0.8 0 ± 0
CG, control group; CPG, cisplatin group; CPBG, cisplatin/bixin group; CPAG, cisplatin/annatto group.
a CPG statistically different from CPBG (p < 0.05).
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Fig. 1. Mean and standard deviation of blood urea dosing (mg/dl) in Wistar rats
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Fig. 2. Mean and standard deviation of blood creatinine dosing (mg/dl) in Wistar
8 h after administering cisplatin. Control group (CG), cisplatin group (CPG), cis-
latin/bixin group (CPBG) and cisplatin/annatto group (CPAG), p > 0.05.
esults and discussion
With respect to hematological analysis, the blood cell dif-
erential count showed a signiﬁcant reduction in neutrophil
ounts (p < 0.05) in the group that received a diet rich in bixin
13.5 ± 3.5%) when compared to the group that received only cis-
latin (24.6 ± 9.2%). No signiﬁcant difference was found between
he groups (p > 0.05) with respect to other blood cells: lymphocytes,
onocytes, basophils and eosinophils (Table 1). The immunolog-
cal response can be divided into adaptive (innate immune) and
on-adaptive components, enhancing the phagocytic capacity of
ells, such as monocytes, macrophages and neutrophils, which act
n the destruction of antigens and constitute the ﬁrst line of human
efense mechanisms (Pathak and Palan, 2005).
In given situations, particularly in the case of acute inﬂamma-
ion, high levels of neutrophils occur. This was observed in the
resent study; however, when the group that received cisplatin
as compared with the group that received cisplatin/bixin, it is
vident that bixin apparently minimized the inﬂammatory effects
f cisplatin, given that it signiﬁcantly (p < 0.05) reduced the levels
f neutrophils, indicating a reduction in antitumor agent-induced
nﬂammation.
No statistically signiﬁcant difference was found between the
roups, with respect to dose in relation to plasma urea levels,
lthough a tendency (p = 0.07) toward decreased urea levels was
bserved in the group receiving dietary bixin/cisplatin in compar-
son to the CG and group receiving annatto/cisplatin, as shown in
ig. 1.
It is important to evaluate plasma creatinine and urea levels
ogether, despite the fact that these two parameters do not always
how concomitant high levels. In cases of prerenal attack, situa-
ions such as protein-rich diet, high protein breakdown rates, and
ehydration, high levels of urea may  be found together with nor-
al  creatinine levels. However, these two dosages change togetherrats  48 h after administering cisplatin. Control group (CG), cisplatin group (CPG),
cisplatin/bixin group (CPBG), and cisplatin/annatto group (CPAG), p > 0.05.
in situations of postrenal attack, where renal obstructions, malig-
nancy, renal excretion disorders and a decrease in the glomerular
ﬁltration rate occur (Burtis et al., 2006).
Urea results from the catabolism of the amino acids, and is elim-
inated from the body, predominantly by the kidneys (Burtis et al.,
2006). Urea is synthesized exclusively by hepatic enzymes and it is
a very unstable marker, since it is inﬂuenced by the protein content
of diets, and thus it is not as accurate as creatinine for evaluating
renal function. However, it serves as a complementary indicator in
the diagnosis of renal injury (Sodré et al., 2007; Burtis et al., 2006).
No signiﬁcant difference between the groups was  found
(p > 0.05) with regard to serum creatinine dosage (Fig. 2). Serum
creatinine dosage is the most commonly used indicator for mon-
itoring the evolution of renal failure, since it is the least variable
nitrogenous compound in the blood. Since it is a residue of creat-
inine, free creatinine is not reused by the body’s metabolism, but
rather excreted through glomerular ﬁltration (Lima et al., 2003).
The macroscopic examination of the kidneys of rats from all
groups showed that they had a normal appearance, with a pink-red
color and ﬁrm consistency. The results of kidney weight in rela-
tion to body weight revealed possible swelling of this organ, which
could be related to local inﬂammatory processes (Table 2).
In the group that received cisplatin, the substance effectively
inhibited an increase in kidney weight – which generally follows
the same pattern as that of body weight – which was statistically
lower in the animals in this group. There was no statistically sig-
niﬁcant difference between the bixin group and the CPG (Table 2).
The results observed in this study corroborate the ﬁndings of other
studies that observed an increase in the kidney–body weight ratio
in rats treated with cisplatin (Saad et al., 2004). It has been sug-
gested that an increase in kidney weight in rats is associated with
nephrotoxicity related to tubular epithelial necrosis caused by cis-
platin (Cadernas and Barja, 1999). A relative increase in kidney
weight and histological changes, together with an increase in the
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Table  2
Mean and standard deviation of the “ﬁnal body weight/kidney weight” ratio in Wistar rats subjected to different treatments.
n Initial weight (g) Final weight (g) Renal weight (g)
CG 6 250.31 ± 13.80 375.71 ± 24.81 1.36 ± 0.10
CPG  6 244.81 ± 16.90 369.42 ± 21.48 1.41 ± 0.21
CPBG  6 249.11 ± 16.70 353.61 ± 10.30 1.38 ± 0.10
CPAG  6 253.01 ± 28.80 347.11 ± 24.89 1.23 ± 0.10a
CG, control group; CPG, cisplatin group; CPBG, cisplatin/bixin group; CPAG, cisplatin/annatto group.
a CPG statistically different from CPBG (p < 0.05).
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cig. 3. Photomicrographs of hematoxylin and eosin stained kidney sections of ra
isplatin/annatto group (CPAG), showing polymorphonuclear inﬁltrates (arrow). M
umber of inﬂammatory cells, were noted in animals that received
nly cisplatin, suggesting a similar association in this group.
The histological analysis of the kidney sections showed that
haracteristic structures were forming in this organ. The presence
f glomeruli was noted in the cortical region, surrounded by twisted
roximal and distal tubules (Fig. 3).
The renal tissue of the animals that received cisplatin showed
olymorphonuclear (PMN) inﬁltrates in the glomerular region,
hich is a characteristic of inﬂammatory changes. However, PMN
nﬁltrates were not present in the kidneys of the animals that
eceived pretreatment with bixin (Fig. 3).
PMN, attracted during the reperfusion process, are considered
mportant mediators during the beginning phase parenchymal
njury in cases of acute ischemic renal failure. On the other hand, the
ate of inﬁltration of mononuclear leukocytes can vary depending
n renal damage (Ysebaert et al., 2004).
According to Faraco (1996), the number of PMN  within the
lomerular capillaries is an indicator of the level of inﬂammatory
ctivity in glomerulopathies, including acute glomerulonephritis
Oliveira, 2005).
Acute glomerulonephritis, in addition to the presence of
acrophages and PMN, is characterized by increased glomerular
olume and a proliferation of the mesangial cells (Faraco, 1996;
liveira, 2005). Glomerular changes were observed in the kidneys
f the CPG, characterized by PMN  inﬁltrates, which could indi-
ate acute glomerulonephritis. However, PMN  inﬁltrates were notthe control group (CG), cisplatin group (CPG), cisplatin/bixin group (CPBG), and
ation 400×.
present in the kidneys of animals who  received pretreatment with
bixin, which suggests that this substance may  afford protection
against inﬂammation typically caused by this antitumor agent.
These results corroborate the ﬁndings of other studies concern-
ing damage caused by cisplatin. A study conducted by Behling et al.
(2006) evaluating the effect of multiple doses of quercetin to inhibit
renal damage caused by cisplatin showed that the administration of
this ﬂavonoid prevents and signiﬁcantly reduces renal damage, and
that treatment with cisplatin without quercetin increases plasma
creatinine levels, lipid peroxidation and renal damage, as shown by
the histological analysis of this organ.
The histological analysis of kidney sections from the group that
received cisplatin/annatto showed that this group did not receive
the same level of protection as that afforded in the bixin group,
despite a reduction in kidney weight. This difference could be
explained by the dosage adopted by the present study, which may
have been excessive. In a study evaluating the protective effect
of annatto and bixin against the genotoxicity of cisplatin in PC12
cells using the micronucleus test, Santos et al. (2012) veriﬁed that
2.0, 3.0 and 4.0 g/ml concentrations of annatto induced genotoxic
damage to the PC12 cells. However, pretreatment with 0.2, 0.5 and
1.0 g/ml concentrations of annatto resulted in a protection rate
of between 66.4% and 76.7% against chromosomal damage induced
by cisplatin. Some carotenoids, when used in very high doses, fail
to present the desired effect and can act as pro-oxidants (Behling
et al., 2006; Rios et al., 2009).
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Tocchini, L., Mercadante, A.Z., 2001. Extrac¸ ão e determinac¸ ão, por CLAE, de bixina e
norbixina em coloríﬁcos. Ciênc. Tecnol. Aliment. 21, 310–313.
Ysebaert, D.K., De Greef, K., De Beuf, A., Van Rompay, A.R., Vercauteren, S., Persy, V.P.,
De  Broe, M.E.T., 2004. Cells as mediators in renal ischemia/reperfusion injury.
Kidney Int. 66, 491–496.50 L.F. Souza et al. / Revista Brasileira
With respect to the proximal and distal tubules, no differences
ere observed between the groups, showing that neither cisplatin
or pretreatment with bixin and annatto had any effect. These
esults are contrary to the ﬁndings of Behling et al. (2006) who,
sing the same dose of cisplatin adopted in the present study
5 mg/kg), noted morphological changes such as tumor-tubular
ecrosis. However, the length of exposure to the drug in the study
arried out by Behling was longer than that of the present study (5
nd 20 days, as compared to just 2 days, respectively).
onclusions
The ﬁndings of this study suggest that exposure time was  suf-
cient to demonstrate that cisplatin caused acute injury and that
ixin probably helped to minimize inﬂammation, as shown by the
ow levels of neutrophils.
However, pretreatment with bixin attenuates kidney damage,
reventing an increase in PMNs, and is a possible protector against
isplatin-induced acute inﬂammatory processes.
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